Cangrelor in Ticagrelor-Loaded STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.07.041
Abstract: The intravenous P2Y12 receptor antagonist cangrelor provides rapid onset and offset of platelet inhibition [(1)][1]. Compared with clopidogrel, cangrelor has significantly reduced the rate of ischemic events, including stent thrombosis, during percutaneous coronary intervention (PCI),… read more here.
Keywords: ticagrelor loaded; cangrelor; cangrelor ticagrelor; percutaneous coronary ... See more keywords